Table 3.
Patient-reported outcome measures selected for the studies included in the review.
| Patient-reported outcome measure | Number of times used n (%) |
|---|---|
| Euroqol-5 Dimension Index | 70 (29.2%) |
| Other Generic measures | 18 (7.5%) |
| European Organization for Research and Treatment of Cancer (EORTC) modules EORTC QLQ-C30 with EORTC disease-specific module EORTC QLQ-C30 without EORTC disease-specific module |
99 (41.3%) 32 (32.3%) 30 (30.3%) |
| Functional Assessment of Chronic Illness Therapy (FACIT) measures FACT-G with FACT disease-specific measure FACT-G without FACT disease-specific measure |
41 (17.1%) 3 (7.3%) 2 (4.9%) |
| Other disease-specific measures | 12 (5%) |
| Total | 240 (100%) |